long-term effects of glp-1 medications Why do patients stop drugs? GLP-1 medications may be one

( post hoc analysis of the TESSA study population demonstrated that 87.5% of participants (28 of 32) exceeded 10 mol/L at 24 h, qualifying as high-TMAO producers by Wu et al

Health Canada warns that prescription weight loss drugs should only be taken under medical supervision

Evaluating the stability of disulfide bridges in proteins: a torsional potential energy surface for diethyl disulfide

The UCDs comprise 8 abnormalities listed in Table 1 altering cofactors, enzymes or transporters [3]

Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: A randomized, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA

They also address the roles of fiber and fermented foods in gut health